Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis
Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic.
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.
The over USD 6.5 billion (by 2030) financial opportunity within the Psychedelic Therapeutics market has been analyzed across the following segments:
Target Disease Indication
- Anxiety and Depression
- Trauma
- Pain Disorder
- Sleep related Disorder
Origin of Psychedelic Substance
- Natural
- Synthetic
Type of Psychedelic Substance
- Gamma-hydroxybutyrate
- Ketamine
- MDMA
- Psilocybin
Route of Administration
- Oral
- Intranasal
- Sublingual
Key Geographies
- North America
- Europe
- Asia-Pacific
The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
- Celon Pharma
- iX Biopharma
- MAPS Public Benefit
- MindMed
- Janssen Pharmaceuticals
- Jazz Pharmaceutical
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Psychedelic Therapeutics
5. Company Profiles
6. Clinical Trial Analysis
7. Clinical Trial Site Analysis
9. Key Opinion Leader (KOL) Analysis
8. Academic Grants Analysis
10. Partnerships and Collaborations
11. Mergers and Acquisitions
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
14733